Viva-SX LLC - Series H

Anshuman Dube is the sole named GP with no prior EDGAR filings on record, signaling either a first-time fund manager entering the formal venture ecosystem or an established operator launching under a new entity—both scenarios warrant LP verification of prior fund experience, exits, and any management transitions.

A mid-2026 venture filing aligns with the post-2025 correction cycle when allocators reassess venture exposure and dry powder deployment; timing suggests Dube is capitalizing on renewed LP appetite for venture after 2024–2025 pullback, though this is speculative without explicit strategy disclosure.

Before engaging, confirm whether Dube has prior fund history under a different legal entity or management structure, verify the actual fund target and strategy in the amended filing, and clarify the GP economics and key-man protections—placeholder filings often mask material terms that shift during the formal raise.